These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9381270)

  • 21. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohematological surveillance of the pregnant woman: new prevention policy].
    Mannessier L
    Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When anti-G and anti-C antibodies masquerade as anti-D antibody.
    Muller CL; Schucker JL; Boctor FN
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):193-4. PubMed ID: 20807156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester].
    Parant O
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
    Carbonne B; Goffinet F; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
    [No Abstract]   [Full Text] [Related]  

  • 30. The introduction of human monoclonal anti-D for therapeutic use.
    Fletcher A; Thomson A
    Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
    [No Abstract]   [Full Text] [Related]  

  • 31. Noninvasive fetal Rh genotyping: the time has come.
    Queenan JT
    Obstet Gynecol; 2005 Oct; 106(4):682-3. PubMed ID: 16199621
    [No Abstract]   [Full Text] [Related]  

  • 32. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 33. [Weak D (Du) phenotype and pregnancy].
    Stefanova A
    Akush Ginekol (Sofiia); 2005; 44(1):54-6. PubMed ID: 15853015
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of feto-maternal Rh isoimmunization].
    Gómez Piña de la Peza ; Lamadrid Montemayor F; Flores Rodríguez JJ
    Ginecol Obstet Mex; 1971 Jan; 29(171):99-104. PubMed ID: 4996660
    [No Abstract]   [Full Text] [Related]  

  • 35. [The causes of failures in post partum Anti-D-prophylaxis. 1. Technical errors and feto-maternal transfusions (author's transl)].
    Schneider J; Bartsch FK
    Geburtshilfe Frauenheilkd; 1973 Oct; 33(10):798-805. PubMed ID: 4203351
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of maternal isoimmunization to RhD antigen].
    Baptista González HA; Rosenfeld Mann F
    Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials.
    Béliard R
    Transfus Clin Biol; 2006; 13(1-2):58-64. PubMed ID: 16580863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to Rh D--development and uses.
    Scott ML; Voak D
    Vox Sang; 2000; 78 Suppl 2():79-82. PubMed ID: 10938934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis.
    de Silva PM; Knight RC
    Transfus Med; 1997 Dec; 7(4):323-4. PubMed ID: 9510934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.